MELISSA BANDELE: Open Payments
NPI 1467636514 · GERMANTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 21 payments from 9 companies in 2025. Trend: 2023 $548 · 2024 $526 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $208 |
| Lilly USA, LLC | 5 | $93 |
| ABBVIE INC. | 3 | $60 |
| Novo Nordisk Inc | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Exact Sciences Corporation | 1 | $30 |
| Becton, Dickinson and Company | 1 | $25 |
| Amgen Inc. | 1 | $18 |
| Seqirus USA Inc | 1 | $17 |
Products named: AIRSUPRA, BREZTRI, UBRELVY, MOUNJARO, JARDIANCE, GARDASIL 9, Cologuard Collection Kit, BD MAX System, BD MAX Instrument.
Industry payments across MD — which companies pay providers there.
